Respiratory Syndrome Coronavirus 2 Infection
📧 Sign up to get email alerts when something new happens for Respiratory Syndrome Coronavirus 2 Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-02-01Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With COVID-19 [Phase 2]
Phase 2 trial update evaluating VB-201 for efficacy and safety in severe COVID-19 patients has completed.
-
CLINICAL_TRIALS trial_result · 2022-08-30Clinical Trial Update: Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure [Phase 2, Phase 3]
Clinical trial update for Dociparstat in adults with severe COVID-19 at high risk of respiratory failure shows termination across Phase 2/3 …
-
CLINICAL_TRIALS trial_result · 2022-05-13Clinical Trial Update: COVID-19: A Study to Evaluate Safety, Reactogenicity and Immunogenicity of the SARS-CoV-2 mRNA Vaccine CVnCoV in Adults With Co-morbidities [Phase 3]
Phase 3 trial of the SARS-CoV-2 mRNA vaccine CVnCoV in adults with comorbidities was terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2021-04-08Clinical Trial Update: Ruxolitinib for Acute Respiratory Disorder Syndrome Due to COVID-19 [Phase 2, Phase 3]
A phase 2/3 trial of ruxolitinib for acute respiratory distress syndrome due to COVID-19 was terminated.
-
CLINICAL_TRIALS trial_result · 2020-09-16Clinical Trial Update: Efficacy and Safety of Early COVID-19 Convalescent Plasma in Patients Admitted for COVID-19 Infection [Phase 2]
Phase 2 trial update evaluating the efficacy and safety of early convalescent plasma collected from COVID-19 patients in individuals admitte…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-07-16Clinical Trial Update: Role of Co-trimoxazole in Severe COVID-19 Patients [Phase 2]
A Phase 2 clinical trial update investigates the role of co-trimoxazole in severe COVID-19 patients.
-
CLINICAL_TRIALS trial_result · 2020-02-07Clinical Trial Update: The Efficacy of Intravenous Immunoglobulin Therapy for Severe 2019-nCoV Infected Pneumonia [Phase 2, Phase 3]
Clinical trial update evaluating intravenous immunoglobulin therapy for severe pneumonia due to 2019-nCoV (COVID-19) across Phase 2 and Phas…